Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Candel Therapeutics, Inc. | 629,000 | reported | 26 Jan 2026 | tx 20+2,136,725−217,059 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Jan 2026 | GRANT_AWARD | Candel Therapeutics, Inc. | 629,000 | 0.00 USD | deriv |
| 25 Jun 2025 | GRANT_AWARD | Candel Therapeutics, Inc. | 42,826 | 4.67 USD | |
| 19 Mar 2025 | SALE | Candel Therapeutics, Inc. | 400 | 9.00 USD | |
| 18 Mar 2025 | SALE | Candel Therapeutics, Inc. | 25,772 | 8.77 USD | |
| 12 Feb 2025 | GRANT_AWARD | Candel Therapeutics, Inc. | 525,000 | 0.00 USD | deriv |
| 15 Jan 2025 | SALE | Candel Therapeutics, Inc. | 21,704 | 7.23 USD | |
| 08 Jan 2025 | SALE | Candel Therapeutics, Inc. | 21,172 | 8.22 USD | |
| 29 Nov 2024 | SALE | Candel Therapeutics, Inc. | 48,847 | 4.56 USD | |
| 21 Nov 2024 | EXERCISE | Candel Therapeutics, Inc. | 12,900 | 1.55 USD | |
| 21 Nov 2024 | EXERCISE | Candel Therapeutics, Inc. | 12,900 | 0.00 USD | deriv |
| 17 Jul 2024 | SALE | Candel Therapeutics, Inc. | 22,528 | 6.47 USD | |
| 11 Jul 2024 | SALE | Candel Therapeutics, Inc. | 20,293 | 5.97 USD | |
| 28 Nov 2023 | TAX_WITHHOLDING | Candel Therapeutics, Inc. | 43,443 | 0.90 USD | |
| 26 Nov 2023 | GRANT_AWARD | Candel Therapeutics, Inc. | 180,108 | 0.00 USD | |
| 28 Apr 2023 | GRANT_AWARD | Candel Therapeutics, Inc. | 180,000 | 0.00 USD | deriv |
| 09 Dec 2022 | PURCHASE | Candel Therapeutics, Inc. | 12,935 | 1.92 USD | |
| 08 Dec 2022 | PURCHASE | Candel Therapeutics, Inc. | 3,050 | 1.70 USD | first after silence |
| 28 Nov 2022 | GRANT_AWARD | Candel Therapeutics, Inc. | 195,906 | 0.00 USD | |
| 28 Feb 2022 | GRANT_AWARD | Candel Therapeutics, Inc. | 330,000 | 0.00 USD | deriv |
| 29 Jul 2021 | PURCHASE | Candel Therapeutics, Inc. | 25,000 | 8.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 08 Dec 2022.